JHL Biotech's Convertible Note Round

JHL Biotech raised a round of funding on May 29, 2018. Investors include VMS Investment Group.

JHL Biotech (喜康生物) is a biopharmaceuticals company that aims to develop, manufacture, and commercialize affordable biologic medicines, particularly focused on biosimilars.…

Articles about JHL Biotech's Convertible Note Round: